3429 studies found for:    Open Studies | "Brain Diseases"
Show Display Options
Rank Status Study
1 Recruiting Magnetic Resonance Biomarkers in Neonatal Encephalopathy
Condition: Neonatal Encephalopathy
Intervention:
2 Recruiting Efficacy, Safety, And Pharmacokinetics Of Rifaximin In Subjects With Severe Hepatic Impairment And Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Interventions: Drug: Placebo;   Drug: Rifaximin
3 Recruiting Sildenafil Administration to Treat Neonatal Encephalopathy
Condition: Neonatal Encephalopathy
Interventions: Drug: Sildenafil;   Drug: Ora-Blend
4 Recruiting Fecal Microbiota Transplantation (FMT) in the Management of Hepatic Encephalopathy (HE): a Pilot Study
Condition: Hepatic Encephalopathy
Intervention: Biological: Fecal Microbiota Transplant
5 Recruiting Nitazoxanide Plus Lactulose Versus Lactulose Alone Treatment of Hepatic Encephalopathy
Condition: Encephalopathy, Hepatic
Interventions: Drug: Nitazoxanide;   Drug: Lactulose
6 Recruiting Real World Outcomes Study of Hepatic Encephalopathy Patients' Experience on Rifaximin (PROSPER)
Condition: Hepatic Encephalopathy
Interventions: Other: Prospective Phase Rifaximin-α 550mg;   Other: Prospective Phase No Rifaximin-α 550mg;   Other: Retrospective Phase
7 Recruiting A Study of the Genetic Analysis of Brain Disorders
Condition: Brain Disorders
Intervention:
8 Recruiting Prognostic Observation of Posterior Reversible Encephalopathy Syndrome
Condition: Posterior Reversible Encephalopathy Syndrome
Intervention:
9 Recruiting A Multi-Center Cohort Study of Risk Factors and Outcomes of Encephalopathy of Prematurity in China
Condition: Encephalopathy
Intervention:
10 Recruiting Hypothermia for Encephalopathy in Low and Middle-Income Countries Trial
Condition: Neonatal Encephalopathy
Intervention: Device: Whole body cooling (Tecotherm)
11 Recruiting Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE)
Conditions: Acute Episode of Overt Hepatic Encephalopathy;   Hepatic Encephalopathy
Interventions: Drug: ornithine phenylacetate;   Drug: placebo intravenous infusion
12 Not yet recruiting Cannabidiol in Children With Refractory Epileptic Encephalopathy
Condition: Epileptic Encephalopathy
Intervention: Drug: CanniMed® 1:20
13 Recruiting Autologous Cord Blood Cell Therapy for Neonatal Encephalopathy
Conditions: Neonatal Encephalopathy;   Hypoxic-ischemic Encephalopathy
Intervention: Other: Autologous umbilical cord blood cells
14 Recruiting Treatment of Human Cord Blood Mononuclear Cell for Delayed Encephalopathy After Carbon Monoxide Poisoning
Condition: Delayed Encephalopathy After Carbon Monoxide Poisoning
Interventions: Biological: Human cord blood mononuclear cell;   Other: hyperbaric oxygen
15 Recruiting Hyperbaric Oxygen Therapy Improves Outcome of Hypoxic-Ischemic Encephalopathy
Condition: Hypoxic-ischemic Encephalopathy
Intervention: Device: hyperbaric oxygen
16 Not yet recruiting Intra-individual Open-label, Single Center Study to Compare Unenhanced MRI With Dotarem Enhanced MRI
Condition: Brain Diseases
Intervention: Drug: Dotarem
17 Recruiting Cytokines Associated With Cord Blood Cell Therapy for Neonatal Encephalopathy
Condition: Neonatal Encephalopathy (Neonatal Hypoxic-ischemic Encephalopathy)
Intervention: Biological: Autologous cord blood cell therapy
18 Recruiting Treatment of Hepatic Encephalopathy With Flumazenil and Change in Cortical GABA Levels in MRS
Conditions: Hepatic Encephalopathy;   Liver Cirrhosis
Interventions: Drug: Flumazenil;   Drug: Placebo
19 Recruiting Metformin Experience on Minimal Hepatic Encephalopathy
Conditions: Liver Cirrhosis;   Hepatic Encephalopathy
Interventions: Drug: Metformin;   Drug: Placebo
20 Recruiting Neural Progenitor Cell and Paracrine Factors to Treat Hypoxic Ischemic Encephalopathy
Condition: Hypoxic-Ischemic Encephalopathy
Interventions: Biological: neural progenitor cell;   Biological: Paracrine factors;   Biological: progenitor cell and paracrine factors

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.